Your browser doesn't support javascript.
loading
Developing an interpretable machine learning model for predicting COVID-19 patients deteriorating prior to intensive care unit admission using laboratory markers.
Reina-Reina, A; Barrera, J M; Maté, A; Trujillo, J C; Valdivieso, B; Gas, María-Eugenia.
Afiliación
  • Reina-Reina A; Lucentia Research. Department of Software and Computing System, University of Alicante, Carretera San Vicente del Raspeig s/n, 03690, Alicante, Spain.
  • Barrera JM; Lucentia Lab, Av. Pintor Pérez Gil, 16, 03540, Alicante, Spain.
  • Maté A; Lucentia Research. Department of Software and Computing System, University of Alicante, Carretera San Vicente del Raspeig s/n, 03690, Alicante, Spain.
  • Trujillo JC; Lucentia Lab, Av. Pintor Pérez Gil, 16, 03540, Alicante, Spain.
  • Valdivieso B; Lucentia Research. Department of Software and Computing System, University of Alicante, Carretera San Vicente del Raspeig s/n, 03690, Alicante, Spain.
  • Gas ME; Lucentia Lab, Av. Pintor Pérez Gil, 16, 03540, Alicante, Spain.
Heliyon ; 9(12): e22878, 2023 Dec.
Article en En | MEDLINE | ID: mdl-38125502
ABSTRACT
Coronavirus disease (COVID-19) remains a significant global health challenge, prompting a transition from emergency response to comprehensive management strategies. Furthermore, the emergence of new variants of concern, such as BA.2.286, underscores the need for early detection and response to new variants, which continues to be a crucial strategy for mitigating the impact of COVID-19, especially among the vulnerable population. This study aims to anticipate patients requiring intensive care or facing elevated mortality risk throughout their COVID-19 infection while also identifying laboratory predictive markers for early diagnosis of patients. Therefore, haematological, biochemical, and demographic variables were retrospectively evaluated in 8,844 blood samples obtained from 2,935 patients before intensive care unit admission using an interpretable machine learning model. Feature selection techniques were applied using precision-recall measures to address data imbalance and evaluate the suitability of the different variables. The model was trained using stratified cross-validation with k=5 and internally validated, achieving an accuracy of 77.27%, sensitivity of 78.55%, and area under the receiver operating characteristic (AUC) of 0.85; successfully identifying patients at increased risk of severe progression. From a medical perspective, the most important features of the progression or severity of patients with COVID-19 were lactate dehydrogenase, age, red blood cell distribution standard deviation, neutrophils, and platelets, which align with findings from several prior investigations. In light of these insights, diagnostic processes can be significantly expedited through the use of laboratory tests, with a greater focus on key indicators. This strategic approach not only improves diagnostic efficiency but also extends its reach to a broader spectrum of patients. In addition, it allows healthcare professionals to take early preventive measures for those most at risk of adverse outcomes, thereby optimising patient care and prognosis.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Heliyon Año: 2023 Tipo del documento: Article País de afiliación: España Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Heliyon Año: 2023 Tipo del documento: Article País de afiliación: España Pais de publicación: Reino Unido